ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity
- 31 October 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 11 (5), 283-296
- https://doi.org/10.1016/j.clbc.2011.03.020
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Breast implant‐associated, ALK‐negative, T‐cell, anaplastic, large‐cell lymphoma: Establishment and characterization of a model cell line (TLBR‐1) for this newly emerging clinical entityCancer, 2010
- Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entityHaematologica, 2010
- Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfallsJournal of Hematopathology, 2009
- Primary and Secondary T-cell Lymphomas of the BreastApplied Immunohistochemistry & Molecular Morphology, 2009
- Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study GroupAnnals Of Oncology, 2009
- Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentationDiagnostic Pathology, 2009
- Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factorsAmerican Journal of Hematology, 2008
- B-Cell and T-Cell Lymphomas of the Breast: Clinical—Pathological Features of 53 CasesInternational Journal of Surgical Pathology, 2008
- Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disordersJournal of the American Academy of Dermatology, 1996
- Cutaneous T-cell lymphoma in association with silicone breast implantsJournal of the American Academy of Dermatology, 1995